Business Description
AroCell AB
ISIN : SE0003883990
Compare
Compare
Traded in other countries / regions
AROC.Sweden80R.Germany IPO Date
2018-07-20Description
AroCell AB is working in the area of cancer diagnostics. The company develops and commercializes markers for the determination of cell growth and apoptosis, clinically useful for prognosis, monitoring, and follow-up of cancer patients in Sweden.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 0.44 | |||||
| Beneish M-Score | -4.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 471.8 | |||||
| 3-Year EBITDA Growth Rate | 38.3 | |||||
| 3-Year EPS without NRI Growth Rate | 5.5 | |||||
| 3-Year FCF Growth Rate | 36.3 | |||||
| 3-Year Book Growth Rate | -0.9 | |||||
| Future 3-5Y Total Revenue Growth Rate | 29.75 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.9 | |||||
| 9-Day RSI | 42.65 | |||||
| 14-Day RSI | 43.84 | |||||
| 6-1 Month Momentum % | -10.74 | |||||
| 12-1 Month Momentum % | -11.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.05 | |||||
| Quick Ratio | 4.52 | |||||
| Cash Ratio | 3.41 | |||||
| Days Inventory | 53.61 | |||||
| Days Sales Outstanding | 58.56 | |||||
| Days Payable | 28.9 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -44 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.55 | |||||
| Operating Margin % | -100.25 | |||||
| Net Margin % | -97.97 | |||||
| FCF Margin % | -12.59 | |||||
| ROE % | -32.92 | |||||
| ROA % | -30.55 | |||||
| ROIC % | -45.57 | |||||
| ROC (Joel Greenblatt) % | -789.45 | |||||
| ROCE % | -33.22 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.71 | |||||
| PB Ratio | 0.68 | |||||
| Price-to-Tangible-Book | 1.04 | |||||
| EV-to-EBIT | -0.89 | |||||
| EV-to-EBITDA | -0.95 | |||||
| EV-to-Revenue | 0.88 | |||||
| EV-to-FCF | -6.74 | |||||
| Price-to-Net-Current-Asset-Value | 1.04 | |||||
| Price-to-Net-Cash | 2.08 | |||||
| Earnings Yield (Greenblatt) % | -111.8 | |||||
| FCF Yield % | -7.23 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
AroCell AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 4.567 | ||
| EPS (TTM) (€) | -0.02 | ||
| Beta | 0.61 | ||
| Volatility % | 61.52 | ||
| 14-Day RSI | 43.84 | ||
| 14-Day ATR (€) | 0.002764 | ||
| 20-Day SMA (€) | 0.02417 | ||
| 12-1 Month Momentum % | -11.92 | ||
| 52-Week Range (€) | 0.0166 - 0.0516 | ||
| Shares Outstanding (Mil) | 230.36 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
AroCell AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
AroCell AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
AroCell AB Frequently Asked Questions
What is AroCell AB(FRA:80R)'s stock price today?
The current price of FRA:80R is €0.02. The 52 week high of FRA:80R is €0.05 and 52 week low is €0.02.
When is next earnings date of AroCell AB(FRA:80R)?
The next earnings date of AroCell AB(FRA:80R) is 2025-02-19.
Does AroCell AB(FRA:80R) pay dividends? If so, how much?
AroCell AB(FRA:80R) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers